MREO
Price
$3.24
Change
-$0.11 (-3.28%)
Updated
Dec 23, 11:31 AM (EDT)
93 days until earnings call
XERS
Price
$3.48
Change
+$0.07 (+2.05%)
Updated
Dec 20, 04:59 PM (EDT)
72 days until earnings call
Ad is loading...

MREO vs XERS

Header iconMREO vs XERS Comparison
Open Charts MREO vs XERSBanner chart's image
Mereo BioPharma Group
Price$3.24
Change-$0.11 (-3.28%)
Volume$1.8K
CapitalizationN/A
Xeris Biopharma Holdings
Price$3.48
Change+$0.07 (+2.05%)
Volume$11.37K
CapitalizationN/A
MREO vs XERS Comparison Chart
Loading...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MREO vs. XERS commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MREO is a Hold and XERS is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (MREO: $3.35 vs. XERS: $3.49)
Brand notoriety: MREO and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MREO: 216% vs. XERS: 88%
Market capitalization -- MREO: $518.19M vs. XERS: $520.29M
MREO [@Biotechnology] is valued at $518.19M. XERS’s [@Biotechnology] market capitalization is $520.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • MREO’s FA Score: 1 green, 4 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, MREO is a better buy in the long-term than XERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MREO’s TA Score shows that 4 TA indicator(s) are bullish while XERS’s TA Score has 4 bullish TA indicator(s).

  • MREO’s TA Score: 4 bullish, 4 bearish.
  • XERS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MREO is a better buy in the short-term than XERS.

Price Growth

MREO (@Biotechnology) experienced а -10.43% price change this week, while XERS (@Biotechnology) price change was +6.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

MREO is expected to report earnings on Mar 26, 2025.

XERS is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XERS($520M) and MREO($518M) have the same market capitalization . XERS YTD gains are higher at: 48.511 vs. MREO (45.022). XERS has higher annual earnings (EBITDA): -23.07M vs. MREO (-43.41M). MREO has more cash in the bank: 80.5M vs. XERS (69.4M). MREO has less debt than XERS: MREO (6.68M) vs XERS (271M). XERS has higher revenues than MREO: XERS (187M) vs MREO (1M).
MREOXERSMREO / XERS
Capitalization518M520M100%
EBITDA-43.41M-23.07M188%
Gain YTD45.02248.51193%
P/E RatioN/AN/A-
Revenue1M187M1%
Total Cash80.5M69.4M116%
Total Debt6.68M271M2%
FUNDAMENTALS RATINGS
XERS: Fundamental Ratings
XERS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MREOXERS
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
83%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
82%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
View a ticker or compare two or three
Ad is loading...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHTAX23.550.30
+1.29%
Diamond Hill Select Inv
SOAUX20.500.26
+1.28%
Spirit of America Utilities A
JDNRX68.910.72
+1.06%
Janus Henderson Growth And Income R
BSGIX17.420.12
+0.69%
Baird Small/Mid Cap Growth Institutional
AFNAX24.66-1.08
-4.19%
Bahl & Gaynor Income Growth A

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+1.82%
MDGL - MREO
37%
Loosely correlated
+5.12%
TERN - MREO
34%
Loosely correlated
-3.14%
INZY - MREO
33%
Loosely correlated
+6.41%
ORIC - MREO
31%
Poorly correlated
+6.76%
XERS - MREO
30%
Poorly correlated
+2.35%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with SCPH. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then SCPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
+2.35%
SCPH - XERS
43%
Loosely correlated
+2.42%
EXAI - XERS
43%
Loosely correlated
N/A
RXRX - XERS
42%
Loosely correlated
-0.99%
FHTX - XERS
39%
Loosely correlated
+3.21%
KROS - XERS
38%
Loosely correlated
+0.65%
More